Takeda’s EXKIVITY (mobocertinib) Approved By FDA As First Oral Therapy Specifically Designed For Patients With EGFR Exon20 Insertion+ NSCLC
Takeda Pharmaceutical Company Limited ((http://www.w3.org/1999/xhtml" rel="nofollow"
Novavax Shares Surge On Vaccine Supply Deal With Japan
Novavax, Inc. (NASDAQ: NVAX) shares were trading higher Tuesday following the signing of a coronavirus vaccine supply deal.
Takeda’s Breakthrough Blood Cancer Drug Flunks In Phase 3 Study
Takeda Pharmaceutical Co Ltd (NYSE:TAK) announced topline data from the Phase 3 PANTHER study evaluating pevonedistat in blood cancer indications. The…
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 1)
Takeda Pharma Offers Update On Phase 3 PANTHER Trial: Says Study Did Not Achieve Statistical Significance For Primary Endpoint
Takeda Pharmaceutical Company Limited ((Takeda Pharmaceutical Company Limited ((TAK) (&ldquo
UK’s NICE Rejects Johnson & Johnson’s Darzalex Regime For Newly Diagnosed Myeloma
New guidance from the National Institute for Health and Care Excellence (NICE) has rejected a combination regimen based on Johnson & Johnson's (NYSE: JNJ) Darzalex for previously untreated patients with multiple myeloma.
Moderna Withdraws Additional COVID-19 Shots In Japan: What You Need To Know
After receiving reports on more contaminated vials and two deaths, Japan has suspended another million doses of Moderna Inc’s (NASDAQ:MRNA) COVID-19 vaccine.…
Suspected Metallic Particles Behind Moderna’s Japan COVID-19 Jab Contamination: Reuters
Metallic particle is believed to be a contaminant found in a batch of Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccines delivered to Japan, Japanese public broadcaster NHK reported, citing sources at the health ministry.
Exelixis – Takeda’s Cabometyx Scores Approval In Japan For Kidney Cancer
Exelixis Inc’s (NASDAQ:EXEL) collaborating partner Takeda Pharmaceutical Co Ltd (NYSE:TAK) and Ono Pharmaceutical Co Ltd have received approval for Cabometyx (cabozantinib) in Japan. The approval…
Moderna Withdraws 1.6M COVID-19 Vaccine Doses In Japan Over Contamination Concerns
More than a million doses of Moderna Inc’s (NASDAQ: MRNA) coronavirus vaccine have been taken out of circulation in Japan after reports of contamination emerged, Nikkei Asia